半岛bd体育手机客户端 说明
一般描述
A cell-permeable piperazinyl-pyrimidine compound that acts as an inhibitor against S6K1 (Ki= 20 nM; IC50= 160 nM) and MSK1 (IC50= 950 nM) kinase activity, exhibiting little or much reduced potency against 85 other protein and lipid kinases (IC50= 4.7, 9.2, 65 ?M, respectively, against RSK1, RSK2, and S6K2; ≤27% inhibition of the rest at 1 ?M). Shown to selectively inhibit IGF1- and PMA-stimulated S6K1 substrates phosphorylation in HEK-293 cells in a dose-dependent manner (up to 10 ?M)in vitroand alleviate heart remodeling and functional damage in a MI (myocardial infarction) model in micein vivo(75/mg/kg/daily i.p.).
A cell-permeable piperazinyl-pyrimidine compound that acts as an inhibitor against S6K1 (Ki= 20 nM; IC50= 160 nM) and MSK1 (IC50= 950 nM) kinase activity, exhibiting little or much reduced potency against a panel of 75 other protein kinases (IC50= 4.7, 9.2, 65 ?M, respectively, against RSK1, RSK2, and S6K2; ≤27% inhibition of the rest at 1 ?M) and 10 lipid kinases (≤6% inhibition at 10 ?M). Inhibits IGF1-induced phosphorylation of cellular S6K1 substrates S6 (Ser235/236and Ser240/244), mTOR (Ser2448), and Rictor (Thr1135) in serum-starved HEK-293 cultures, but not the phoshorylation of MSK or RSK cellular substrates (CREB Ser133and GSK3α/β Ser21/ Ser9, respectively) upon PMA stimulation even at concentrations as high as 10 ?M. Inhibition of S6K1 activation by rapamycin (Cat. Nos. 553210, 553211, & 553212) or S6K1 activity by PF-4708671 (75/mg/kg/daily i.p.) are both shown to alleviate heart remodeling and functional damage following left coronary artery ligation-induced MI (myocardial infarction) in micein vivo. Cellular PF-4708671 treatment is also reported to result in increased S6K1 phosphorylation, likely due to a blockage of down-stream negative feedback mechanism.
包装
10 mg in Glass bottle
Packaged under inert gas
警告
Toxicity: Standard Handling (A)
重悬
Following reconstitution, aliquot and freeze (-20°C.) Stock solutions are stable for up to 6 months at -20°C.
其他说明
Di, R., et al. 2012.Biochem. J.441,199.
Pearce, L.R., et al. 2010.Biochem. J.431,245.
法律信息
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
基本信息
经验(实验)分子式 | C19H21F3N6 |
分子量 | 390.41 |
MDL编号 | MFCD18086922 |
半岛bd体育手机客户端 性质
质量水平 | 100 |
测定 | ≥98% (HPLC) |
形式 | solid |
manufacturer/tradename | Calbiochem? |
储存条件 | OK to freeze protect from light |
颜色 | off-white |
溶解性 | DMSO: 50 mg/mL, pale yellow |
运输 | ambient |
储存温度 | 2-8℃ |
安全信息
储存分类代码 | 11 - Combustible Solids |
WGK | WGK 3 |
闪点(F) | Not applicable |
闪点(C) | Not applicable |
Sigma-Aldrich